DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Olson CM, Jiang B, Erb MA. et al.
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.
Nat Chem Biol 2018;
14 (02) 163-170
We do not assume any responsibility for the contents of the web pages of other providers.